Evidence map›Paper›PMID 37658292›Full record

ArticleBMC public health2023

Cost analysis of an innovative eHealth program in Nigeria: a case study of the vaccine direct delivery system.

Ryoko Sato, Loveth Metiboba, Jamil Aliyu Galadanchi, Mohammed-Faosy Adeniran, Sadiq Haruna Hassan, David Akpan, Juliet Odogwu, Busayo Fashoto

Abstract read
In one paragraph

Article in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryoko SatoHarvard T.H. Chan School of Public Health, MA, Boston, USA.
Loveth MetibobaeHealth Africa, Abuja, Nigeria. loveth.metiboba@ehealthnigeria.org.
Jamil Aliyu GaladanchieHealth Africa, Abuja, Nigeria.
Mohammed-Faosy AdeniraneHealth Africa, Abuja, Nigeria.
Sadiq Haruna HassaneHealth Africa, Abuja, Nigeria.
David AkpaneHealth Africa, Abuja, Nigeria.
Juliet OdogwueHealth Africa, Abuja, Nigeria.
Busayo FashotoeHealth Africa, Abuja, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionVaccine stockout is a severe problem in Africa, including Nigeria, which could have an adverse effect on vaccination coverage and even health outcomes among the population. The Vaccine Direct Delivery (VDD) program was introduced to manage vaccine stockouts using eHealth technology. This study conducts a cost analysis of the VDD program and calculates the incremental costs of reaching an additional child for vaccination through the VDD program.

methodsWe used the expense reports from eHealth Africa, an NGO which implemented the VDD program, to calculate the VDD program's overall operating costs. We also used the findings from the literature to translate the effect of VDD on the reduction of vaccine stockouts into its effect on the increase in vaccination coverage. We calculated the incremental costs of reaching an additional child for vaccination through the VDD program.

resultsWe calculated that implementing the VDD program cost USD10,555 monthly for the 42 months that the VDD program was operating in Bauchi state. This figure translates to an incremental cost of USD20.6 to reach one additional child for vaccination. DISCUSSION/

conclusionsOur study is one of the first to conduct a cost analysis of eHealth technology in Africa. The incremental cost of USD20.6 was within the range of other interventions that intended to increase vaccine uptake in low- and middle-income countries. The VDD program is a promising technology to substantially reduce vaccine stockout, leading to a reduction of over 55% at a reasonable cost, representing 26% of the total budget for routine immunization activities in Bauchi state. However, there is no comparable costing study that evaluates the cost of a supply chain strengthening intervention. Future studies should investigate further the feasibility of eHealth technology, as well as how to minimize its costs of implementation while keeping the efficacy of the program.

Indexed as

TelemedicineVaccinesChildCosts and Cost AnalysisHumansNigeriaVaccinationVaccinesCost analysiseHealth technologyNigeriaVaccine direct deliveryVaccine stockouts

Identifiers

PMID37658292
PMCPMC10472608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.